Dosing Strategies for Automated Mandatory Intermittent Boluses Technique for Epidural Labour Analgesia
Information source: Pravara Institute of Medical Sciences University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Primigravida in Labour Pains.
Intervention: Bupivacaine-Fentanyl Mixture (Drug); Bupivacaine-Fentanyl Mixture (Drug); Bupivacaine-Fentanyl Mixture (Drug)
Phase: N/A
Status: Withdrawn
Sponsored by: Pravara Institute of Medical Sciences University Official(s) and/or principal investigator(s): Dr.Mandar V Galande, MBBS, Principal Investigator, Affiliation: Pravara Rural Hospital Dr.Ramchandra V Shidhaye, MD DA, Principal Investigator, Affiliation: Pravara Rural Hospital Dr.Devdas S Divekar, MD DA, Principal Investigator, Affiliation: Pravara Rural Hospital, Loni
Summary
The purpose of this study is to determine how manipulation of the programmed intermittent
time interval and volume influences total drug use, quality of analgesia, and patient
satisfaction during maintenance of labor analgesia.
Clinical Details
Official title: A Randomized, Control Study to Evaluate Dosing Strategies for Automated Mandatory Intermittent Boluses Technique for Epidural Labour Analgesia
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Total epidural bupivacaine dose
Secondary outcome: DemographicsQuality of analgesia (Cumulative analgesia scores ) Level of analgesia (VAS score) Maternal satisfaction No.of doses omitted No.of Additional top-ups required Duration of labour Maternal Safety Foetal Safety
Detailed description:
Research for the ideal technique of maintaining epidural analgesia after the initial-level
block is ongoing. Continuous infusion techniques, use of more dilute solutions , PCEA , and
different techniques of PCEA like background dosing, none, fixed infusion as background,
variable infusion (computer-integrated), programmed intermittent boluses (PIEBs) and
automated mandatory boluses, have been used. Automated systems designed to administer a
small bolus dose of anaesthetic at programmable intervals may combine the advantages of both
manual bolus and continuous epidural infusion (CEI) systems.
Wong et al compared a PIEB (6 ml of bolus every 30 minutes) with CEI with the assumption
that small frequent boluses may avoid wide fluctuations in sensory levels, commonly seen
with traditional manually administered intermittent boluses and at the same time reduce the
total anesthetic dose as in CEI. Chua and Sia showed that Pain scores were lower and the
time to first manual epidural rescue bolus was longer in parturients assigned to
intermittent boluses compared to continuous epidural infusion of the same solution in the
intermittent group. Fettes and colleagues found that patients required a lower total drug
dose and fewer manual bolus injections when epidural labor analgesia was maintained with
automated intermittent boluses of ropivacaine compared to a continuous infusion. Solutions
injected into the epidural space tend to spread more evenly when injected as a bolus, as
compared to a continuous infusion. Furthermore, studies of epidural opioid analgesia suggest
that epidural bolus administration of lipid soluble opioids (e. g., fentanyl) results in
segmental spinal opioid analgesia, whereas continuous opioid epidural infusion results in
systemic opioid analgesia. The analgesic effects of both epidural fentanyl infusion and
epidural fentanyl bolus were evaluated using a volunteer, double blind, cross-over designs
study. Taken together, the results of these studies suggest that further studies of
automated intermittent bolus injections are indicated, in particular, studies of the optimal
bolus time interval and volume. At one end of the spectrum, a short interval/low volume
protocol may mimic a continuous infusion. At the other end of the spectrum, a long
interval/large volume may negate the inherent safety of a continuous infusion. The purpose
of the proposed study is to determine how manipulation of the programmed intermittent time
interval and volume influences total drug use, quality of analgesia, and patient
satisfaction during maintenance of labor analgesia.
Current pump technology does not support programmed intermittent bolus administration. The
investigators encouraged the manufacturer to develop these features indigenously and
incorporate them in presently available infusion pumps.
Methods:
Study will be carried out in randomly selected sixty uncomplicated full term pregnant
patients, in active labour.
After written, informed, valid consent, and administration of five hundred millilitres of
Ringer's lactate intravenously as a preload, epidural catheter will be inserted under
aseptic conditions in an L2-L3 or L3-L4 space through 16 G Tuohy's needle. Epidural space
will be identified through the loss-of-resistance technique. The catheter will be placed,
cephaled, two spaces (3 to 4 cm) above the point of insertion.
Its position will be confirmed by administering a test dose of 3 ml of lignocaine (2%) with
adrenaline.
A loading-dose mixture of 10 ml of bupivacaine (0. 125%) and fentanyl (2 µg/ml) will be
administered epidurally targeting initial sensory block to T 10 level .Additional doses of
Inj. bupivacaine will be administered if required.
Infusion pump will be attached to the catheter and all patients will be randomly divided in
three groups.
1. Group 3-15 : Three millilitres of mixture of bupivacaine (0. 125%) with fentanyl (2
µg/ml) injected through epidural catheter every 15 minutes as automated boluses
2. Group 4-20: Four millilitres of mixture of bupivacaine (0. 125%) with fentanyl (2
µg/ml) injected through epidural catheter every 20 minutes.
3. Group 6-30: Six millilitres of mixture of bupivacaine (0. 125%) with fentanyl (2 µg/ml)
injected through epidural catheter every 30 minutes.
Randomization will be carried out based on blocking. Blocks of size 3 with treatment
allocation of 1: 1:1 for group I, group II and group III will be created. A block of 3
patients will be assigned to one of the blocks created.
For blinding of patient as well observer, the settings of infusion pump will be hidden by
covering it with cloth.
The level of sensory blockade will be tested by a pinprick method in midline and motor
blockade will be tested with the modified Bromage scale used by Breen et al.
A single dose will be omitted if the sensory block goes higher than T7 or the motor blockade
goes below score 4 as per the Bromage scale. Similarly additional top-ups of 3 ml of 0. 125 %
bupivacaine with fentanyl 2 micrograms / ml will be administered if patients get severe
break through pain (VAS pain score > 3)
. Maternal parameters like pulse rate, blood pressure and respiratory rate will be monitored
frequently. FHR will be monitored through tococardiography. Bearing-down ability will be
assessed by asking the patients about the perception of the urge to bear down. Neonates will
be assessed by Apgar score at 1 minute and 5 minutes after birth. The patients will be
observed for any side effects or complications, such as pruritus, nausea and vomiting,
hypotension, a headache, sedation and respiratory depression. Labour analgesic drug
administration will be stopped after delivery and the duration of labour analgesia will be
recorded. The total dose of bupivacaine and fentanyl will be calculated. The quality of
analgesia will be assessed hourly. The patients will be asked about pain relief during the
last hour and will be given scores as follows:
- 0 = No pain, pressure or tightening sensation
- 1 = Awareness of pressure or tightening sensation but not painful
- 2 = Slight pain or pressure sensation but not distressing
- 3 = Distressing pain or pressure sensation Even when the patients scored higher for a
very short period, the higher score will be recorded for that hour. All the patients
will be interviewed within 24 hours of delivery by an anaesthetist colleague who will
unaware of the technique used and recorded a linear visual analogue scale (VAS) pain
score on the patient's opinion about overall efficacy of analgesia. On this scale, 0
cm will indicate no pain and 10 cm will indicate worst pain. They will also ask about
the level of their satisfaction regarding the quality of analgesia, which will be
graded as 'excellent', 'good' and 'bad'.
Statistical analysis will be carried out with Stata 11.
Eligibility
Minimum age: 18 Years.
Maximum age: 35 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Full term women in spontaneous labor.
- Gestation greater than or equal to 37 weeks.
- Primigravida.
- Age group between 18 Years to 45 Years.
- ASA grade I or II
- Not having any complicated pregnancy
- Not having any systemic disorders.
Exclusion Criteria:
- Not willing for Epidural analgesia.
- Unwilling to get enrolled in this study.
- Systemic disorder like diabetes mellitus, hypertension and heart disease, spine
deformity, blood coagulation disorder, bad obstetric history and foetal abnormity.
- Multiple-pregnancy or abnormal presentation.
- Complicated pregnancy like pregnancy induced hypertension, placenta previa, abruptio
placenta.
- Cervical dilatation less than 2 or greater than 5 at time of initiation of neuraxial
analgesia.
- Chronic analgesic medications
- Systemic opioid labor analgesia prior to the initiation of neuraxial labor analgesia.
Locations and Contacts
Additional Information
Starting date: August 2010
Last updated: May 4, 2015
|